Under the plan, Israel would be allowed to annex about 30% of the West Bank, Jerusalem won't be divided and Hamas must give up their weapons.
Former US National Security Adviser H. R. McMaster tells "Globes" that Israel is unwittingly helping Iran by making no demands on Russia.
After trials with Tesco and Shufersal, Israel's Trigo is moving into retail chains worldwide with its ceiling cameras and software that eliminate the need for checkout counters.
The coldness between Benjamin Netanyahu and Reuven Rivlin was evident, but it was the prime minister who laid the groundwork for the gathering of world leaders.
Israel Chemicals and ecological researchers have warned about the environmental dangers posed by Channel 11's newly discovered river many times in the past.
Chemicals & plastics
The first pedestrian bridge over the Ayalon is also the only one of 10 bridges that has a bicycle lane.
Transport & infrastructure
The Alaskan Native Corporations are an example of how we should use gas revenues to give all Israelis a greater share in their country's wealth.
The revised Israel-UK Protocol now in force has been warmly welcomed.
Ben Gurion University researcher Dr. Tomer Hertz says flu jabs, like vaccinations against childhood diseases, are a social act that helps prevent infecting others.
Ashdod plans 15 hotels with 4,000 rooms built in the coming decade for its seafront with cheaper prices for tourists than Tel Aviv.
Michael Li, founder and president of The Data Incubator, talks about the need for more data scientists worlwide and in Israel.
It isn't Hamas rockets - the answer lies closer to home.
The poverty report is about inequality, not children without food. The report's authors and media ignore this and make demagogic statements, says Dr. Michael Sarel.
The gas from Leviathan came ashore on time, exports look set, but Israeli factories still await hook-up, and no-one even knows who should decide on conflicts with Tamar.
After the biggest ever Israeli cybersecurity company exit, the founders say they remain independent and retain their vision of an IPO and building a huge IoT security company.
Mergers & acquisitions
VP discovery David Wilson tells "Globes" that Teva is still an innovative company and has turned its attention back to Israel in the search for new drug candidates.
Co-founder Hillel Kobrinsky: We looked for a business problem, and then developed the technology, not the other way around.